Literature DB >> 19949862

Ultrasound-guided percutaneous microwave coagulation therapy with a "cooled-tip needle" for the treatment of hepatocellular carcinoma adjacent to the gallbladder.

Wei-Dong Pan1, Rong-Qin Zheng, Lin Nan, He-Ping Fang, Bo Liu, Zhao-Feng Tang, Mei-Hai Deng, Rui-Yun Xu.   

Abstract

BACKGROUND: Curative percutaneous microwave coagulation therapy is difficult or contraindicated in patients with tumors adjacent to the gallbladder because of the associated risk of injury. To date, no clinical data have been published regarding the effects and safety of percutaneous microwave coagulation therapy on tumors that are adjacent to the gallbladder. AIMS: We investigated the efficacy and safety of a combined treatment involving laparoscopic cholecystectomy and subsequent percutaneous microwave coagulation therapy in patients with hepatocellular carcinoma adjacent to the gallbladder.
METHODS: Twenty-three patients with hepatocellular carcinoma nodules (of less than 5 cm diameter) and adjacent to the gallbladder were treated by percutaneous microwave coagulation therapy with a "cooled-tip needle" after laparoscopic cholecystectomy. The therapeutic efficacy was evaluated with enhanced helical computed tomography and sonography, and the rates of complete necrosis as well as postoperative complications were also analyzed.
RESULTS: All of the patients exhibited complete necrosis of their tumor lesions after treatment with percutaneous microwave coagulation therapy. During the follow-up period (which lasted more than 21 months), 22 of 23 patients were alive. Recurrent nodules appeared in other subsegments, but not at the original site treated with percutaneous microwave coagulation therapy. Of note, no fatal complications were observed in any of the patients treated with percutaneous microwave coagulation therapy.
CONCLUSION: Our results suggest that combined treatment comprising both laparoscopic cholecystectomy and subsequent percutaneous microwave coagulation therapy is an effective and safe approach for patients with small (<5 cm) hepatocellular carcinomas that are adjacent to the gallbladder.

Entities:  

Mesh:

Year:  2009        PMID: 19949862     DOI: 10.1007/s10620-009-1053-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  25 in total

Review 1.  Radiofrequency tumor ablation: principles and techniques.

Authors:  S N Goldberg
Journal:  Eur J Ultrasound       Date:  2001-06

2.  Thermal ablation therapy for hepatocellular carcinoma: comparison between radiofrequency ablation and percutaneous microwave coagulation therapy.

Authors:  Kenji Ohmoto; Naoko Yoshioka; Yasuyuki Tomiyama; Norikuni Shibata; Tomoya Kawase; Koji Yoshida; Makoto Kuboki; Shinichiro Yamamoto
Journal:  Hepatogastroenterology       Date:  2006 Sep-Oct

Review 3.  Treatment options for hepatocellular carcinoma.

Authors:  Dalbir S Sandhu; Vivek S Tharayil; Jin-Ping Lai; Lewis R Roberts
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2008-02       Impact factor: 3.869

4.  Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma.

Authors:  T Seki; M Wakabayashi; T Nakagawa; T Itho; T Shiro; K Kunieda; M Sato; S Uchiyama; K Inoue
Journal:  Cancer       Date:  1994-08-01       Impact factor: 6.860

5.  Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas.

Authors:  Kenji Ohmoto; Naoko Yoshioka; Yasuyuki Tomiyama; Norikuni Shibata; Tomoya Kawase; Koji Yoshida; Makoto Kuboki; Shinichiro Yamamoto
Journal:  J Gastroenterol Hepatol       Date:  2008-09-24       Impact factor: 4.029

Review 6.  Hepatocellular carcinoma: current management and recent advances.

Authors:  Wan-Yee Lau; Eric C H Lai
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2008-06

7.  Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: a meta-analysis.

Authors:  Y-F Yang; W Zhao; Y-D Zhong; H-M Xia; L Shen; N Zhang
Journal:  J Viral Hepat       Date:  2009-02-12       Impact factor: 3.728

Review 8.  Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies.

Authors:  Yun Ku Cho; Jae Kyun Kim; Mi Young Kim; Hyunchul Rhim; Joon Koo Han
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

9.  Ultrasound-guided percutaneous thermal ablation of hepatocellular carcinoma using microwave and radiofrequency ablation.

Authors:  H-X Xu; X-Y Xie; M-D Lu; J-W Chen; X-Y Yin; Z-F Xu; G-J Liu
Journal:  Clin Radiol       Date:  2004-01       Impact factor: 2.350

10.  Polymorphism analyses of hepatitis B virus X gene in hepatocellular carcinoma patients from southern China.

Authors:  Ping'an Zhu; Deming Tan; Zhongtian Peng; Fei Liu; Lin Song
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2007-04       Impact factor: 3.848

View more
  3 in total

Review 1.  Practice guidelines for ultrasound-guided percutaneous microwave ablation for hepatic malignancy.

Authors:  Ping Liang; Jie Yu; Ming-De Lu; Bao-Wei Dong; Xiao-Ling Yu; Xiao-Dong Zhou; Bing Hu; Ming-Xing Xie; Wen Cheng; Wen He; Jian-Wen Jia; Guo-Rong Lu
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

2.  The effect of lipiodol deposition in HCC after TACE on the necrosis range of PMCT.

Authors:  HongLiang Sun; JiaYan Ni; XiongYing Jiang; Dong Chen; YaoTing Chen; LinFeng Xu
Journal:  Onco Targets Ther       Date:  2017-08-01       Impact factor: 4.147

3.  Efficacy and safety of percutaneous microwave ablation for hepatocellular carcinomas <4 cm in difficult location.

Authors:  Amar Mukund; Ravindran Ramalingam; Karan Manoj Anandpara; Yashwant Patidar; Rajan Vijayaraghavan; Shiv Kumar Sarin
Journal:  Br J Radiol       Date:  2020-10-06       Impact factor: 3.039

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.